Gemini BioProjects LLC was established in 2002 as a resource to all those engaged in communicating the science of business and the business of science. Our practice blends in-depth understanding of the biosciences and drug development processes with expertise in corporate and marketing communications as well as investor and media relations. This uncommon mix of skills and expertise is paralleled by an uncommon approach to client service. At Gemini BioProjects, we understand that the dynamic environment found in the life science industries leads inevitably to an ebb and flow in our clients’ communications needs. While the practice is able and available to develop and implement a comprehensive suite of communications strategies, our goal is to provide precisely those services that our clients need, when they need them. This flexible approach enables Gemini BioProjects to serve as either the sole provider of external communications support or as part of a team. Our clients can utilize our capabilities for specific projects or to fill an ongoing need. We pride ourselves on our ability to tailor our strategies, services, and fees to match our clients’ needs: No long-term commitments, no minimum fees, nothing unnecessary. We believe that the quality of our work and our commitment to excellence will keep our clients coming back.


Strategic Planning

  • Message development
  • Positioning
  • Developing/implementing communications programs


  • Press releases/Press kits
  • Annual reports
  • Corporate fact sheets
  • Technology backgrounders
  • SEC documents
  • Technical documents
  • Scientific manuscripts
  • By-lined articles
  • Web site content
  • Corporate presentations
  • Marketing materials

Investor/Media Relations

  • Contacting/building relationships with members of the financial and media communities

Event Planning



  • Gene/cell therapy
  • Gene editing/functional genomics
  • Small-molecule drugs
  • Monoclonal antibodies
  • Therapeutic proteins
  • Cancer vaccines
  • Immunotherapies

Disease Indications

  • Oncology
  • Autoimmune diseases
  • Inherited retinal diseases
  • Cardiovascular disease
  • Viral infectious diseases
  • Genetic disorders
  • Gastrointestinal disorders
  • Coagulation and hemostasis
  • Diabetes and metabolic disorders

Corporate Issues

  • SEC disclosure/Reg FD
  • Crisis management
  • Image management
  • Employee communications
  • Outreach to patient advocacy groups

Stephanie H. Seiler, Ph.D.
Gemini BioProjects LLC
2729 233rd Street SW, Brier, WA 98036